Neurocrine Biosciences Stock Target Price and Analyst Consensus
| NBIX Stock | USD 137.76 1.21 0.87% |
The current analyst and expert consensus on Neurocrine Biosciences is Strong Buy with 6 buy recommendations. The current projected Neurocrine Biosciences target price consensus is 133.45, with 29 analyst opinions. The most common way Neurocrine Biosciences analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Neurocrine Biosciences executives, vendors, and/or customers. Neurocrine Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Neurocrine Biosciences target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Neurocrine Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.
Lowest Forecast 121.44 | Highest Forecast 148.13 | Target Price 133.45 |
Neurocrine |
It's important to approach Neurocrine Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Neurocrine Biosciences price targets
Neurocrine Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Neurocrine Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Neurocrine Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Neurocrine Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Neurocrine Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Neurocrine Biosciences is a key component of Neurocrine Biosciences valuation and have some predictive power on the future returns of a Neurocrine Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neurocrine Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested few shares | |
 | Warren Buffett Holdings Invested over 40 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Investor Favorites Invested few shares | |
 | Business Services Invested few shares | |
Check out Macroaxis Advice on Neurocrine Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Neurocrine Stock analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
The data published in Neurocrine Biosciences' official financial statements usually reflect Neurocrine Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Neurocrine Biosciences. For example, before you start analyzing numbers published by Neurocrine accountants, it's critical to develop an understanding of what Neurocrine Biosciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Neurocrine Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neurocrine Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Neurocrine Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Neurocrine Biosciences. Please utilize our Beneish M Score to check the likelihood of Neurocrine Biosciences' management manipulating its earnings.